Journal of International Oncology ›› 2019, Vol. 46 ›› Issue (11): 686-691.doi: 10.3760/cma.j.issn.1673-422X.2019.11.009

Previous Articles     Next Articles

Mechanism of RhoA in malignant tumors

Sun Guangshun1, Mei Jie2, Zhou Meng3, Wu Di3, Pan Jiadong2, Liu Xiao1   

  1. 1Department of Thyroid and Breast Surgery, Wuxi People′s Hospital Affiliated to Nanjing Medical University, Wuxi 214023, China; 2Department of Oncology, Wuxi People′s Hospital Affiliated to Nanjing Medical University, Wuxi 214023, China; 3First Clinical College, Nanjing Medical University, Nanjing 211166, China
  • Online:2019-11-08 Published:2019-12-26
  • Contact: Liu Xiao E-mail:liuxiaowuxi@126.com

Abstract: As a representative member of the Rho family, RhoA plays an important role in the oncogenesis and development of malignant tumors. According to previous studies, RhoA functions as a key regulator in mediating actin polymerization, cytoskeletal structure remodeling, cell polarity changes, epithelial-mesenchymal transition and so on. RhoA can promote multiple malignant phenotypes of tumor cells, such as migration, invasion, etc. At present, mainstream research believes that RhoA functions as oncogene in the carcinogenesis of tumors. Downregulated RhoA can inhibit tumor growth and progression, which can be used as a potential target for clinical anti-tumor therapy. 

Key words: Neoplasms, Neoplasm metastasis, Cytoskeleton, RhoA